Discordant response to rituximab in a systemic sclerosis patient with associated myositis

Journal of the American Academy of Dermatology

Volumn 58, Issue 5 SUPPL. 1, 2008, Pages

  Fabri, Mario ^a   Hunzelmann, Nicolas ^a   Krieg, Thomas ^a   Rubbert, Andrea ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISOLONE; RITUXIMAB;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; HUMAN; LABORATORY TEST; MALE; MYOSITIS; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; HUMANS; MALE; MYOSITIS; SCLERODERMA, SYSTEMIC;

EID: 41849147093     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.06.010     Document Type: Article

References (5)

1. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger Jr. T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
2. Pope J. Musculoskeletal involvement in scleroderma. Rheum Dis Clin North Am 29 (2003) 391-408
3. Noss E.H., Hausner-Sypek D.L., and Weinblatt M.E. Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol 33 (2006) 1021-1026
4. Lafyatis R, Kissin E, Viger K, Merkel P, Simms R. Rituximab treatment for patients with diffuse cutaneous systemic sclerosis: a phase I study (abstract). ACR/ARHP Annual Scientific Meeting 2006, Washington, DC, November 10-15, 2006.
5. Hasegawa M., Hamaguchi Y., Yanaba K., Bouaziz J.D., Uchida J., Fujimoto M., et al. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 169 (2006) 954-966